Bacterin Intl Hldgs (BONE) 5.30 $BONE
IRadimed (IRMD) Jumps: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 8:25AM CDT
IRadimed (IRMD) was a big mover last session, with shares rising over 7% on the day.
Mazor Robotics (MZOR) Jumps: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:25AM CDT
Mazor Robotics (MZOR) was a big mover last session, with shares rising nearly 7% on the day.
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and Echo Therapeutics
PR Newswire - Wed Sep 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Bacterin International Holdings, Inc. (AMEX:BONE-Free Report), Inogen, Inc. (Nasdaq:INGN-Free Report) and Echo Therapeutics, Inc. (Nasdaq:ECTE-Free Report).
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
Bruker Slips to Strong Sell on Poor 2H14 Performance View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 5:32PM CDT
In the reported quarter, Bruker's (BRKR) revenues grossed $457.4 million, missing the Zacks Consensus Estimate by 0.11%
ERBA Diagnostics, Inc. (ERB) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 8:32AM CDT
ERBA Diagnostics, Inc. (ERB) was a big mover last session, as the company saw its shares rise 6% on the day.
Cyberonics Slips to Sell on U.S. Woes, Estimate Revisions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 2:00PM CDT
Despite witnessing appreciable growth in the international market, Cyberonics (CYBX) experienced a slack business in the U.S.
Cyberonics Misses on Q1 Earnings & Revenues, Reaffirms View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:40AM CDT
Cyberonics' (CYBX) revenues increased 4.5% year over year to $72.0 million in the quarter, but missed the Zacks Consensus Estimate by 2.7%
Cyberonics Slumps: CYBX Falls 6.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 7:39AM CDT
Cyberonics has been witnessing a flat earnings estimate revisions for the current year and its share price is declining for past month
CVS/pharmacy Survey Focuses on Flu Vaccines for Seniors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 5:20PM CDT
Customers will receive 20% discount on the CVS Caremark's (CVS) CVS/pharmacy Shopping Pass once they get a flu shot at CVS/pharmacy or MinuteClinic.
CVS Caremark's MinuteClinic Starts Operations in Sacramento - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 15, 2:20PM CDT
MinuteClinic is the retail medical clinic division of CVS Caremark (CVS) and is the fastest growing provider of walk-in retail medical clinic services in the U.S.
Greatbatch Acquires Uruguay-based CCC Medical Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 3:30PM CDT
With the acquisition of CCC Medical Devices, Greatbatch, Inc. (GB) aims to enhance its medical device innovation efforts.
Masimo's SpHb Aids Hemoglobin Assessment in Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 2:40PM CDT
Researchers have found that Masimo Corporation's (MASI) SpHb can help clinicians non-invasively assess hemoglobin levels and trending in pediatric patients, leading to better clinical decisions and improved patient outcomes.
Techne Fiscal Q4 Earnings Beat Estimates; Shares Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 9:30AM CDT
Techne Corp. (TECH) posted a 7.3% rise in adjusted earnings per share to 88 cents for the fourth quarter fiscal 2014 (ended Jun 30, 2014) from 82 cents in the year-ago quarter.
Bacterin Announces the Appointment of New Board Member
GlobeNewswire - Wed Aug 13, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of David Goodman, MD, MSE to the board of directors. Dr. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and EVP of Business Development for Masimo (Nasdaq:MASI). The Board unanimously elected Dr. Goodman to fill the vacancy created by Mitchell Godfrey's recent resignation. Bacterin would like to thank Mr. Godfrey for his years of service and dedication to the Company.
Bacterin Announces Second Quarter 2014 Results
GlobeNewswire - Tue Aug 12, 4:42PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today reported financial results for the second quarter ended June 30, 2014. The Company reported quarterly revenues of approximately $8.9 million, and a net loss for the quarter of approximately ($1.9) million, or ($0.35) per common share.
Bacterin Announces Publication in The Spine Journal Featuring OsteoSelect DBM Putty
GlobeNewswire - Tue Aug 12, 6:48AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today The Spine Journal has published positive results reported on the evaluation of OsteoSelect(R) DBM Putty in a rabbit posterolateral spinal fusion model. The study was completed by the Integrated Spine Research Department at the Hospital for Special Surgery in New York.
Bacterin concludes USD5.8m public offering
M2 - Thu Aug 07, 7:13AM CDT
Medical bone graft company Bacterin International Holdings (NYSE MKT:BONE) disclosed on Wednesday that it has raised net proceeds of about USD5.8m, after deducting underwriting discounts, commissions and other expenses, from an underwritten public offering.
Bacterin Announces Closing of Public Offering of Common Stock
GlobeNewswire - Wed Aug 06, 3:51PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the completion of its previously announced underwritten public offering of 1,143,000 shares of its common stock at $5.70 per share and warrants to purchase 571,500 shares of its common stock at an exercise price of $7.12 per share to the public. Net proceeds from the offering were approximately $5.8 million, after deducting underwriting discounts, commissions and other expenses.
Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery
GlobeNewswire - Tue Aug 05, 8:01AM CDT
Bacterin International Holdings, Inc. (NYSE:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today that The Journal of Foot & Ankle Surgery has published a study on the "Role of Demineralized Allograft Subchondral Bone in the Treatment of Shoulder Lesions of the Talus: Clinical Results with Two-Year Follow-up." This study followed the use of OsteoSponge(R) SC in the treatment of medial shoulder lesions of the talus, with positive clinical outcomes at 2 years post-op. The talus has two 'shoulders' which are the outer edges of the talus, a bone in the ankle joint commonly injured as a result of an ankle sprain.
IRadimed (IRMD) Jumps: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 8:25AM CDT
IRadimed (IRMD) was a big mover last session, with shares rising over 7% on the day.
Mazor Robotics (MZOR) Jumps: Stock Moves 6.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 04, 8:25AM CDT
Mazor Robotics (MZOR) was a big mover last session, with shares rising nearly 7% on the day.
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Bacterin International Holdings, Inogen and Echo Therapeutics
PR Newswire - Wed Sep 03, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Bacterin International Holdings, Inc. (AMEX:BONE-Free Report), Inogen, Inc. (Nasdaq:INGN-Free Report) and Echo Therapeutics, Inc. (Nasdaq:ECTE-Free Report).
3 Top-Ranked Medical Equipment Stocks to Buy Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:08PM CDT
The fiscal 2015 budget for the Department of Health and Human Services (HHS) has brought a fresh lease on life to the U.S. healthcare economy, following the past years' debacle.
Bruker Slips to Strong Sell on Poor 2H14 Performance View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 5:32PM CDT
In the reported quarter, Bruker's (BRKR) revenues grossed $457.4 million, missing the Zacks Consensus Estimate by 0.11%
ERBA Diagnostics, Inc. (ERB) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 8:32AM CDT
ERBA Diagnostics, Inc. (ERB) was a big mover last session, as the company saw its shares rise 6% on the day.
Cyberonics Slips to Sell on U.S. Woes, Estimate Revisions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 2:00PM CDT
Despite witnessing appreciable growth in the international market, Cyberonics (CYBX) experienced a slack business in the U.S.
Cyberonics Misses on Q1 Earnings & Revenues, Reaffirms View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:40AM CDT
Cyberonics' (CYBX) revenues increased 4.5% year over year to $72.0 million in the quarter, but missed the Zacks Consensus Estimate by 2.7%
Cyberonics Slumps: CYBX Falls 6.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 7:39AM CDT
Cyberonics has been witnessing a flat earnings estimate revisions for the current year and its share price is declining for past month
CVS/pharmacy Survey Focuses on Flu Vaccines for Seniors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 5:20PM CDT
Customers will receive 20% discount on the CVS Caremark's (CVS) CVS/pharmacy Shopping Pass once they get a flu shot at CVS/pharmacy or MinuteClinic.
CVS Caremark's MinuteClinic Starts Operations in Sacramento - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 15, 2:20PM CDT
MinuteClinic is the retail medical clinic division of CVS Caremark (CVS) and is the fastest growing provider of walk-in retail medical clinic services in the U.S.
Greatbatch Acquires Uruguay-based CCC Medical Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 3:30PM CDT
With the acquisition of CCC Medical Devices, Greatbatch, Inc. (GB) aims to enhance its medical device innovation efforts.
Masimo's SpHb Aids Hemoglobin Assessment in Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 2:40PM CDT
Researchers have found that Masimo Corporation's (MASI) SpHb can help clinicians non-invasively assess hemoglobin levels and trending in pediatric patients, leading to better clinical decisions and improved patient outcomes.
Techne Fiscal Q4 Earnings Beat Estimates; Shares Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 9:30AM CDT
Techne Corp. (TECH) posted a 7.3% rise in adjusted earnings per share to 88 cents for the fourth quarter fiscal 2014 (ended Jun 30, 2014) from 82 cents in the year-ago quarter.
Bacterin Announces the Appointment of New Board Member
GlobeNewswire - Wed Aug 13, 6:30AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of David Goodman, MD, MSE to the board of directors. Dr. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and EVP of Business Development for Masimo (Nasdaq:MASI). The Board unanimously elected Dr. Goodman to fill the vacancy created by Mitchell Godfrey's recent resignation. Bacterin would like to thank Mr. Godfrey for his years of service and dedication to the Company.
Bacterin Announces Second Quarter 2014 Results
GlobeNewswire - Tue Aug 12, 4:42PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today reported financial results for the second quarter ended June 30, 2014. The Company reported quarterly revenues of approximately $8.9 million, and a net loss for the quarter of approximately ($1.9) million, or ($0.35) per common share.
Bacterin Announces Publication in The Spine Journal Featuring OsteoSelect DBM Putty
GlobeNewswire - Tue Aug 12, 6:48AM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today The Spine Journal has published positive results reported on the evaluation of OsteoSelect(R) DBM Putty in a rabbit posterolateral spinal fusion model. The study was completed by the Integrated Spine Research Department at the Hospital for Special Surgery in New York.
Bacterin concludes USD5.8m public offering
M2 - Thu Aug 07, 7:13AM CDT
Medical bone graft company Bacterin International Holdings (NYSE MKT:BONE) disclosed on Wednesday that it has raised net proceeds of about USD5.8m, after deducting underwriting discounts, commissions and other expenses, from an underwritten public offering.
Bacterin Announces Closing of Public Offering of Common Stock
GlobeNewswire - Wed Aug 06, 3:51PM CDT
Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the completion of its previously announced underwritten public offering of 1,143,000 shares of its common stock at $5.70 per share and warrants to purchase 571,500 shares of its common stock at an exercise price of $7.12 per share to the public. Net proceeds from the offering were approximately $5.8 million, after deducting underwriting discounts, commissions and other expenses.
Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery
GlobeNewswire - Tue Aug 05, 8:01AM CDT
Bacterin International Holdings, Inc. (NYSE:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today that The Journal of Foot & Ankle Surgery has published a study on the "Role of Demineralized Allograft Subchondral Bone in the Treatment of Shoulder Lesions of the Talus: Clinical Results with Two-Year Follow-up." This study followed the use of OsteoSponge(R) SC in the treatment of medial shoulder lesions of the talus, with positive clinical outcomes at 2 years post-op. The talus has two 'shoulders' which are the outer edges of the talus, a bone in the ankle joint commonly injured as a result of an ankle sprain.
